Table 2.
Distribution of subjects according to their symptomatology (n=51)
| Symptoms | Initial | 3 mo | 6 mo | p-value |
|---|---|---|---|---|
| Pain | <0.001a) | |||
| Absent | 0 | 34 (66.7) | 49 (96.1) | |
| Mild | 0 | 17 (33.3) | 2 (3.9) | |
| Moderate | 0 | 0 | 0 | |
| Severe | 51 (100.0) | 0 | 0 | |
| Swelling | <0.001a) | |||
| Absent | 0 | 48 (94.1) | 51 (100.0) | |
| Mild | 0 | 3 (5.9) | 0 | |
| Moderate | 20 (39.2) | 0 | 0 | |
| Severe | 31 (60.8) | 0 | 0 | |
| Deformity | <0.001a) | |||
| Absent | 0 | 33 (64.7) | 46 (90.2) | |
| Mild | 2 (3.9) | 18 (35.3) | 5 (9.8) | |
| Moderate | 38 (74.5) | 0 | 0 | |
| Severe | 11 (21.6) | 0 | 0 | |
| Weakness upper limb | 0 | 0 | 0 | - |
| Weakness lower limb | 49 (96.1) | 18 (35.3) | 12 (23.5) | <0.001b) |
| Incontinence | 0 | 0 | 2 (3.9) | 0.135b) |
| Retention | 46 (90.2) | 16 (31.4) | 10 (19.6) | <0.001b) |
Values are presented as number (%).
a)
By Friedman analysis of variance test.
b)
By Cochran’s Q test.